Clinical Trials
18
Active:0
Completed:15
Trial Phases
5 Phases
Phase 1:3
Phase 2:5
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Phase 2
5 (33.3%)Not Applicable
4 (26.7%)Phase 1
3 (20.0%)Phase 3
2 (13.3%)Phase 4
1 (6.7%)Triage Test for All Oral DR-TB Regimen (TRiAD Study)
Completed
- Conditions
- Drug Resistant TuberculosisTuberculosisMDR-TBXDR-TB
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2025-06-26
- Target Recruit Count
- 786
- Registration Number
- NCT05175794
- Locations
- 🇪🇹
Ethiopian Public Health Institute (EPHI), Gulele, Addis Ababa, Ethiopia
🇳🇬Institute of Human Virology Nigeria, Yaba, Lagos State, Nigeria
🇿🇦CAPRISA Springfield Research Clinic, Durban, KwaZulu-Natal, South Africa
INSTI's For The Management of HIV-associated TB
Phase 2
Completed
- Conditions
- HIV/AIDSTuberculosis, Pulmonary
- First Posted Date
- 2021-02-02
- Last Posted Date
- 2025-08-15
- Target Recruit Count
- 122
- Registration Number
- NCT04734652
- Locations
- 🇿🇦
CAPRISA Springfield Clinical Research Site, Durban, KwaZulu-Natal, South Africa
Promoting Engagement in the Drug Resistant TB-HIV Care Continuum in South Africa PRAXIS Study
Not Applicable
Completed
- Conditions
- Adherence, Patient
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2023-02-08
- Target Recruit Count
- 171
- Registration Number
- NCT04032730
- Locations
- 🇿🇦
King Dinuzulu Hospital, Durban, KwaZulu Natal, South Africa
STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women
Not Applicable
Completed
- Conditions
- HIV PreventionSexually Transmitted Diseases
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2018-01-26
- Target Recruit Count
- 267
- Registration Number
- NCT03407586
- Locations
- 🇿🇦
CAPRISA, Durban, KwaZulu-Natal, South Africa
The Individualized M(X) Drug-resistant TB Treatment Strategy Study
Phase 4
Terminated
- Conditions
- Tuberculosis, Multidrug-Resistant
- Interventions
- Drug: Individualized TB treatment with multiple drugsDrug: Standardized TB treatment with multiple drugs
- First Posted Date
- 2017-08-02
- Last Posted Date
- 2023-09-01
- Target Recruit Count
- 205
- Registration Number
- NCT03237182
- Locations
- 🇿🇦
King Dinuzulu Hospital, Durban, Kwa-Zulu Natal, South Africa
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found